Baxter, one of the larger firms in the dialysis business (but nowhere that powerful in the clinic business), made an announcement that it is planning to spin off its renal care and acute therapies unit into another public company. It expects to complete the divestiture in 2024 or so.
Continue reading Memories- with an averted nightmare →
